The effect of Re promoter on Cu/γ-Al2O3 catalysts with various Cu: Re molar ratios was comprehensively investigated in comparison to the monometallic Cu/γ-Al2O3 and Re/γ-Al2O3 catalysts. The...
The novel bifunctional NiÀ Re supported on bimodal SAPO-11 catalyst was designed for an economically combined process of direct triglycerides hydro-deoxygenation and isomerization into low-cold flow diesel. The catalyst with a Ni to Re molar ratio of 1 : 0.12 exhibited superior performance for diesel production containing large fraction of iso-alkanes in comparison to Ni and Re benchmarks. Comprehensive characterizations revealed that the detection of Ni and Re co-existed with NiO and ReO x on SAPO-11 after the reduction confirmed by XRD, XANES, and XPS analysis gave a large distribution of Lewis acid sites (> 80 %) noticed by Pyridine-DRIFTS measurement. Under investigations of WHSV, reaction temperature, and H 2 pressure, the NiRe 0.12 catalyst contributed a nearly theoretical 77.1 % liquid yield, accompanied by a 18.2 % jet-range and 52.1 % diesel-range yields with a classification for 46.8 % iso-alkanes and 23.5 % normal alkanes yields; whereas, the cold-flow properties of liquid product were in the ranges of winter diesel standard. It was remarkably noticed that the combination effects of Ni and nanosized Re species substantially improved the diesel production comprising iso-alkanes components with proper catalyst lifetime and low carbon deposition attributing to the fabricated active metal species on bimodal SAPO-11 features with large distribution of Lewis acidic sites.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.